Viewing 0 reply threads
  • Author
    • #11222

      An inhaled form of messenger RNA (mRNA) with the potential to safely deliver therapeutics to the lungs of cystic fibrosis (CF) patients has been discovered by researchers at the Massachusetts Institute of Technology (MIT).

      Researchers developed a type of nanoparticle given as an inhaled mist (nebulizer) that allows the delivery of mRNAs to the lungs of mice. This kind of carrier may be used to administer mRNA therapeutics directly to the lungs of people with CF and other lung diseases, researchers say.

      Click here to learn more.

      Do you use an inhaled carrier like this to treat your CF?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account